IFP Advisors’s ProPhase Labs PRPH Stock Holding History

IFP Advisors’s Portfolio PRPH Stock Details PRPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-83	Closed	-$6.05K	–	3494
2023 Q2	$6.05K	Buy	+83	New	+$6.75K	﹤0.01%	2480

Other funds holding PRPH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

IFP Advisors's PRPH Position: Q3 2023 in Review

IFP Advisors sold out of ProPhase Labs (PRPH) in Q3 2023, closing a stake of 83 shares — an estimated $6.05K sold.

IFP Advisors first reported a position in PRPH in Q2 2023 and held it in 1 quarter. The position peaked at $6.05K in Q2 2023. 35 funds tracked by Wall St. Rank hold PRPH as of Q3 2023.

IFP Advisors reported no remaining ProPhase Labs position as of Q3 2023 after selling out during the quarter.
IFP Advisors sold 83 ProPhase Labs shares in Q3 2023, an estimated $6.05K.
IFP Advisors first reported a position in ProPhase Labs in Q2 2023 and held it in 1 quarter.
IFP Advisors's ProPhase Labs position peaked at $6.05K in Q2 2023.
35 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2023.

Based on IFP Advisors's 13F filing for Q3 2023, filed 12 Oct 2023.